Drugs / TMVP1-ICG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03320772 | May 2017 → May 2018 | cervical cancer | Huazhong University of Science and Technology | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TMVP1-ICG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03320772 ↗ |
| Modality | Diagnostic / imaging agent | “novel tumor targeted fluorescent TMVP1-ICG” NCT03320772 ↗ |
| Route | Other | “0.4ml of TMVP1-ICG solution was injected into the cervix” NCT03320772 ↗ |